- Conditions
- Adenocarcinoma, Adnexal Diseases, Amyloidosis, +130 more
- Locations
-
- Mayo Clinic in Florida Jacksonville, Florida, United States
Clinical trial condition
Urothelial Carcinoma
Explore clinical trials studying Urothelial Carcinoma. Study availability and eligibility vary by location and protocol.
239 public trials
74 recruiting studies
Urothelial Carcinoma trial results
Recruiting
DBC-664 in Adult Patients With Solid Tumors
NCT07705035
- Conditions
- Adenocarcinoma, Adenocarcinoma of Lung, Carcinoma, +14 more
- Locations
-
- START Midwest Grand Rapids, Michigan, United States
- START New Jersey East Brunswick, New Jersey, United States
- START New York Lake Success, New York, United States
Recruiting
A Study of BL-B01D1 + PD-1 in Patients With Locally Advanced or Metastatic Urothelial Carcinoma
NCT06405425
- Conditions
- Carcinoma, Carcinoma, Transitional Cell, Neoplasms, +3 more
- Locations
-
- Fudan University Shanghai Cancer Center Shanghai, Shanghai Municipality, China
Recruiting
A Study of Disitamab Vedotin Alone or With Pembrolizumab in Urothelial Cancer That Expresses HER2
NCT04879329
- Conditions
- Carcinoma, Carcinoma, Transitional Cell, Female Urogenital Diseases, +13 more
- Locations
-
- Banner Gateway Medical Center Gilbert, Arizona, United States
- Banner MD Anderson Cancer Center Gilbert, Arizona, United States
- Kaiser Permanente Anaheim Kraemer Medical Offices Anaheim, California, United States
- Foothill Cardioology Arcadia, California, United States
Recruiting
A Study to Learn About the Study Medicine Called PF-08046876 in People With Advanced Solid Tumors
NCT07090499
- Conditions
- Adenocarcinoma, Adenocarcinoma Of Esophagus, Adenocarcinoma of Lung, +50 more
- Locations
-
- City of Hope National Medical Center Duarte, California, United States
- City of Hope at Irvine Lennar Irvine, California, United States
- Ronald Reagan UCLA Medical Center Los Angeles, California, United States
- UCLA Department of Medicine-Hematology/Oncology Los Angeles, California, United States
NCT06293898
- Conditions
- Adnexal Diseases, Biliary Tract Cancer, Biliary Tract Diseases, +51 more
- Locations
-
- University of Alabama Birmingham Birmingham, Alabama, United States
- City of Hope Duarte, California, United States
- Cedars Sinai Los Angeles, California, United States
- Scripps Health San Diego, California, United States
NCT06047379
- Conditions
- Adenocarcinoma, Astrocytoma, Brain Diseases, +93 more
- Locations
-
- Precision NextGen Oncology Beverly Hills, California, United States
- OPN Healthcare, Inc Glendale, California, United States
- University of Southern California Los Angeles, California, United States
- MDR Core Network Boynton Beach, Florida, United States
NCT06966024
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +17 more
- Locations
-
- Dana-Farber Cancer Institute Boston, Massachusetts, United States
- University of Michigan Ann Arbor, Michigan, United States
- Fox Chase Cancer Center Philadelphia, Pennsylvania, United States
- Vanderbilt- Ingram Cancer Center Nashville, Tennessee, United States
Recruiting
Study of Neoadjuvant Enfortumab Vedotin and Pembrolizumab in Upper Tract Urothelial Cancer
NCT06356155
- Conditions
- Carcinoma, Carcinoma, Transitional Cell, Neoplasms, +3 more
- Locations
-
- University of Michigan Comprehensive Cancer Center Ann Arbor, Michigan, United States
- Fox Chase Cancer Center Philadelphia, Pennsylvania, United States
Recruiting
Registry Platform Urologic Cancer
NCT03374267
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +16 more
- Locations
-
- Multiple sites, Germany Multiple Locations, Germany